Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ESLA · NASDAQ · Biological Products, (No Diagnostic Substances)
Estrella Immunopharma (ESLA) · oqro.io/stocks/ESLA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$0.38−0.134 (−26.07%)
Close of Nov 16, 2026, vs Nov 13 · end-of-day, not a live quote
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Armistice Capital, LLC now owns 8.4% of ESLA as a passive investorSourceInsider trade · Traded Sep 22, 2025 · Filed Apr 30, 2026
CFO purchased ~$1.2K of ESLA shares in the open marketSourceInsider trade · Traded Oct 7, 2025 · Filed Apr 30, 2026
CFO purchased ~$1.3K of ESLA shares in the open marketSourceInsider trade · Traded Sep 11, 2025 · Filed Apr 30, 2026
CFO purchased ~$104 of ESLA shares in the open marketSource